| Title |
Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2014
|
| DOI | 10.1002/14651858.cd008439.pub3 |
| Pubmed ID | |
| Authors |
Lun Li, Jin Hui Tian, KeHu Yang, Peng Zhang, Wen Qin Jia |
| Abstract |
PRO 140 (a humanized form of the PA14 antibody, a monoclonal CCR5 antibody) inhibits CCR5-tropic (R5) type 1 human immunodeficiency virus (HIV). This may be an effective new treatment with the potential to address the limitations of currently available therapies for HIV-infected patients. |
Twitter Demographics
The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 27% |
| Malawi | 1 | 9% |
| Australia | 1 | 9% |
| United Kingdom | 1 | 9% |
| Ireland | 1 | 9% |
| Unknown | 4 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 73% |
| Science communicators (journalists, bloggers, editors) | 2 | 18% |
| Practitioners (doctors, other healthcare professionals) | 1 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 155 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 153 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 27 | 17% |
| Student > Bachelor | 23 | 15% |
| Researcher | 14 | 9% |
| Student > Ph. D. Student | 14 | 9% |
| Unspecified | 13 | 8% |
| Other | 31 | 20% |
| Unknown | 33 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 32% |
| Nursing and Health Professions | 16 | 10% |
| Unspecified | 13 | 8% |
| Psychology | 7 | 5% |
| Social Sciences | 6 | 4% |
| Other | 22 | 14% |
| Unknown | 41 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 January 2022.
All research outputs
#3,160,857
of 22,805,349 outputs
Outputs from Cochrane database of systematic reviews
#5,838
of 12,315 outputs
Outputs of similar age
#32,989
of 229,615 outputs
Outputs of similar age from Cochrane database of systematic reviews
#111
of 235 outputs
Altmetric has tracked 22,805,349 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,315 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.4. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 229,615 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 235 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.